A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease (NAFLD). The randomized controlled trial published in The American Journal of Gastroenterology found that fecal transplants in patients with NAFLD result in a reduction in how easily pathogens and other unwanted molecules pass through the human gut and into circulation, known as intestinal permeability.
- Study helps explain declines in death rates from COVID-19
- Wildfires can cause dangerous debris flows
- Technology shines the light on ovarian cancer treatments
- Thymoquinone induces apoptosis & DNA damage in 5-Fluorouracil-resistant colorectal cancer
- Oncotarget: quantitative ultrasound radiomics in prediction of treatment response for breast cancer